Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Potassium substitution via the oral route: Does its efficacy depend on the anion of the potassium salt?

  • 42 Accesses

  • 1 Citations

Summary

In an open, randomized study, we investigated the effect of oral potassium chloride (KCl) and of potassium citrate/bicarbonate (K-cit/bic) in 42 patients with hypokalemia (≤3.5 mmol/l). In both groups 80 mmol K+ were administered daily. The parameters examined were serum potassium concentration, acid-base status, and urinary electrolyte excretion. Parameters were evaluated on days 0, 2, 4, and 6. With KCl, [K+] increased from 3.2± 0.2 (mean± SD) on day 0 to 3.8± 0.4 mmol/l on day 2 (p<0.005) and 4.0± 0.5 mmol/l on day 4 (p< 0.005). On day 6 [K+] was also 4.0±0.4 mmol/l (p< 0.005 vs day 0). With K-cit/bic, [K+] increased from 3.2± 0.2 to 3.7± 0.4 on day 2, 3.9± 0.5 on day 4, and 4.1± 0.6 mmol/l on day 6 (allp< 0.005 vs day 0). The increase of [K+] was not different between the two groups. Blood pH on day 0 was in the normal range in both groups and did not change significantly during the study. There was a decrease of carbon dioxide partial pressure (pCO2) with KCl from 38.7± 4.9 on day 0 to 36.4± 3.6 on day 2 (p<0.05). On days 4 and 6, pCO2 was back up to the basal level. In contrast, with K-cit/bic, pCO2 rose from 35.0±5.8 mmHg on day 0 to 39.9± 5.8 mmHg on day 2 (p< 0.05). On days 4 and 6, pCO2 was not different from day 0. The increase in urinary potassium excretion was equal in both groups. These results indicate that oral substitution with either KCl or K-citrate/bicarbonate may have only minor effects on the acid-base status under the conditions of the present study. Both potassium salts appeared to be equally effective in correcting hypokalemia via the oral route.

This is a preview of subscription content, log in to check access.

Abbreviations

GFR:

glomerular filtration rate

K-bic:

potassium bicarbonate

K-cit:

potassium citrate

KCl:

oral potassium chloride

pCO2 :

carbon dioxide partial pressure

t.i.d.:

three times a day

References

  1. 1.

    Down PF, Polak A, Rao R, Mead JA (1972) Fate of potassium supplements in six outpatients receiving long-term diuretics for oedematous disease. Lancet II:721–724

  2. 2.

    Dyncker T, Helmers C, Wester PO (1984) Cardiac dysrhythmias in patients with acute myocardial infarction: relation to serum potassium level and prior diuretic therapy. Acta Med Scand 216:127–132

  3. 3.

    Fournier G, Pfaff-Poulard C, Methani K (1987) Rapid correction of hypokalemia via the oral route (Letter to the editor). Lancet I:163

  4. 4.

    Grimm RH, Neaton JD, Elmer PJ, Svendsen KH, Levin J, Segal M, Holland L, Witte LJ, Clearman DR, Kofron P, LaBounty RK, Crow R, Prineas RJ (1990) The influence of oral potassium chloride on blood pressure in hypertensive men on a low-salt diet. N Engl J Med 322:569–574

  5. 5.

    Haalboom JRE, Struyvenberg A (1982) The mechanism underlying chlorthalidone-induced hypokalemia: effects of sodium restriction, potassium supplementation, spironolactone, and triamterene. Neth J Med 25:184–195

  6. 6.

    Johannson BW, Dziamski R (1984) Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective β-blockade. Drugs 28 [Suppl 1]: 77–85

  7. 7.

    Kaplan NM, Carnegie A, Raskin P, Heller JA, Simmons M (1985) Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med 312:746–749

  8. 8.

    Koshman MA (1974) Management of potassium problems during long-term diuretic therapy. JAMA 230:743–748

  9. 9.

    Morgan DB, Young RM (1982) Acute transient hypokalemia: new interpretation of a common event. Lancet II: 751–752

  10. 10.

    Nodrehaug JE, von der Lippe G (1983) Hypokalemia and ventricular fibrillation in acute myocardial infarction. Br Heart J 50:525–529

  11. 11.

    Papademetriou V, Price M, Johnson E, Smith M, Freis ED (1984) Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol 54:1015–1019

  12. 12.

    Ramsay LE, Boyle P, Ramsay MH (1977) Factors influencing serum potassium in treated hypertension. Q J Med 46:401–410

  13. 13.

    Schwartz AB, Swartz CD (1984) Dosage of potassium chloride elixir to correct thiazide-induced hypokalemia. JAMA 230:702–704

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Meyer-Lehnert, H., Evers, W.M. & Krück, F. Potassium substitution via the oral route: Does its efficacy depend on the anion of the potassium salt?. Klin Wochenschr 69, 797–801 (1991). https://doi.org/10.1007/BF01744272

Download citation

Key words

  • Hypokalemia
  • Oral potassium substitution
  • Acid-Base Status